… in GUSTO IV-ACS was whether the intravenous administration of the glycoprotein IIb/IIIa
receptor blocker abciximab, … infarction in patients with high-risk acute coronary syndromes (ST-…

… revascularisation. An ACS was defined as chest pain and either ST-… randomised, multicentre
trial to study the effect of the glycoprotein IIb/IIIa blocker abciximab on patients with acute …

… 7800 patients in GUSTO IV-ACS and relate these outcomes to … for early revascularization,
routine use of abciximab did not … with abciximab and other GP IIb/IIIa receptor blockers have …

… glycoprotein IIb/IIIa receptor antagonist abciximab reduces the risk of thrombotic complications
with percutaneous coronary … action in the future might further improve outcome in selected …

… Simoons ML: Effect of glycoprotein IIb/IIIa receptor blocker abciximab … outcome in patients
with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS …

… The unexpected negative outcome of GUSTO IV-ACS has led to modification and … Sir—In
the GUSTO-IV ACS study we note no benefit with abciximab in … coronary revascularisation. …

… Open occluded arteries (GUSTO-IV) trials with abciximab. This … recent trials of GP IIb/IIIa
inhibitors and early revascularization … GUSTO IV-ACS Investigators: Effect of glycoprotein IIb/IIIa …

… directed against GP IIb/IIIa block this receptor, prevent binding … coronary revascularization,
the clinical efficacy of GP IIb/IIIa … , the GUSTO-IV trial (29) failed to show efficacy of abciximab …

… , different glycoprotein IIb/IIIa receptor blockers, including abciximab facilitate clot lysis … Sir—In
the GUSTO-IV ACS study we note no benefit with abciximab in … coronary revascularisation. …

… glycoprotein IIb/IIIa receptor blocker, abciximab, on outcome in … on the effect of abciximab
in patients with acute coronary … We judge the definition of ACS in the GUSTO IV-ACS trial, …